These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3124188)

  • 1. Naloxone in tardive dyskinesia.
    Blum I; Nisipeanu PF; Roberts E
    Psychopharmacology (Berl); 1987; 93(4):538. PubMed ID: 3124188
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone may be beneficial in the treatment of tardive dyskinesia.
    Blum I; Munitz H; Shalev A; Roberts E
    Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose naloxone in tardive dyskinesia.
    Lindenmayer JP; Gardner E; Goldberg E; Opler LA; Kay SR; van Praag HM; Weiner M; Zukin S
    Psychiatry Res; 1988 Oct; 26(1):19-28. PubMed ID: 3070611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone and naltrexone in mental illness and tardive dyskinesia.
    Volavka J; Anderson B; Koz G
    Ann N Y Acad Sci; 1982; 398():97-102. PubMed ID: 6760771
    [No Abstract]   [Full Text] [Related]  

  • 5. Enkephalin, morphine, and naloxone in tardive dyskinesia.
    Bjørndal N; Casey DE; Gerlach J
    Psychopharmacology (Berl); 1980; 69(2):133-6. PubMed ID: 6779305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem for tardive dyskinesia.
    Leys D; Vermersch P; Danel T; Comayras S; Goudemand M; Caron J; Petit H
    Lancet; 1988 Jan; 1(8579):250-1. PubMed ID: 2893079
    [No Abstract]   [Full Text] [Related]  

  • 7. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia.
    Sandyk R; Fisher H
    J Clin Psychopharmacol; 1989 Apr; 9(2):147-8. PubMed ID: 2723133
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind study of lecithin in the treatment of persistent tardive dyskinesia.
    Pérez-Cruet J; Menéndez I; Alvarez-Ghersi J; Falcón JR; Valderrábano O; Castro-Urrutia EC; Ifarraguerri C; Pérez LL
    Bol Asoc Med P R; 1981 Nov; 73(11):531-7. PubMed ID: 6121562
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxone, tardive dyskinesia, and endogenous beta-endorphin.
    Reker D; Anderson B; Yackulic C; Cooper TB; Banay-Schwartz M; Leon C; Volavka J
    Psychiatry Res; 1982 Dec; 7(3):321-4. PubMed ID: 6298849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of high dose naloxone to relieve tardive dyskinesia.
    Newhouse PA; Tariot PN; Gross M; Murphy DL; Cohen RM
    J Clin Psychopharmacol; 1987 Oct; 7(5):364-5. PubMed ID: 3680616
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone and tardive dyskinesia.
    Sandyk R; Snider SR
    Biol Psychiatry; 1985 Dec; 20(12):1335-6. PubMed ID: 4063426
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of tardive dyskinesia with baclofen.
    Glazer WM; Moore DC; Bowers MB; Bunney BS; Roffman M
    Psychopharmacology (Berl); 1985; 87(4):480-3. PubMed ID: 3936106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA agonist treatment improves tardive dyskinesia.
    Tamminga CA; Thaker GK; Ferraro TN; Hare TA
    Lancet; 1983 Jul; 2(8341):97-8. PubMed ID: 6134975
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of lithium treatment in established tardive dyskinesia.
    MacKay AV; Sheppard GP; Saha BK; Motley B; Johnson AL; Marsden CD
    Psychol Med; 1980 Aug; 10(3):583-7. PubMed ID: 7003639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of baclofen on tardive dyskinesia.
    Gerlach J; Rye T; Kristjansen P
    Psychopharmacology (Berl); 1978 Mar; 56(2):145-51. PubMed ID: 417365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
    Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sodium valproate on tardive dyskinesia--revisited.
    Fisk GG; York SM
    Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.